HOME
Hepatitis B
Hepatitis C
HIV and AIDS
HIV-HCV Coinfection
HIV-HBV Coinfection
Hepatitis B Main Section
FDA-approved Treatments
 Experimental Treatments
 HBV Articles by Topic

HBV - Liver Fibrosis

Impact of Adefovir (Hepsera) on Liver Fibrosis and Histological Activity Assessed Using FibroTest-ActiTest in Hepatitis B Patients - 12/07/07

Liver Stiffness Measurement (FibroScan) More Useful for Assessing Fibrosis in Patients with HCV Compared with HBV - 12/04/07

Serum Adiponectin Increases with Advancing Liver Fibrosis in People with Chronic Hepatitis B    - 7/17/07

Hepatitis B Patients Who Spontaneously Clear HBeAg and Achieve Sustained Remission have Reduced Liver Fibrosis Progression - 10/19/07

Good Hepatitis B Treatment Outcomes in Patients with Advanced Liver Fibrosis or Cirrhosis - 9/14/07

Efficacy of Entecavir and Lamivudine in Chronic Hepatitis B Patients with Advanced Fibrosis or Cirrhosis  - 5/01/07

Liver Inflammation and Fibrosis Can Occur in Hepatitis B Patients with Normal ALT  - 4/27/07

Non-invasive Technique for Assessing Fibrosis in Hepatitis B Patients  11/21/06

Five-year Treatment with Adefovir Results in Regression of Liver Fibrosis in Patients with HBeAg-negative Chronic Hepatitis B - 11/16/05

Can Green Tea Help Ameliorate Liver Fibrosis?   11/14/06

 


 

 

 

 

 

 

 


HBV Articles on
FDA-approved Therapies
for Chronic HBV Infection

Baraclude  (entecavir)
 Epivir-HBV  (lamivudine; 3TC)
 Hepsera   (adefovir dipivoxil)
Intron A  (interferon alfa-2b)
Pegasys  (peginterferon alfa-2a)
 Tyzeka   (telbivudine)